Cerebrospinal fluid and urinary biomarkers in multiple sclerosis
Authors:
- 7 March 2013
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 128 (5) , 321-327
Abstract
Objectives Biomarkers with the potential for longitudinal measurements are needed in multiple sclerosis (MS). Urine is easy to collect, and repeated sampling is possible. Methods 39 paired CSF and urine samples were taken. Oligoclonal bands (OCBs) were measured in CSF. Kappa and lambda free light chain (FLC), neopterin and ubiquitin C‐terminal hydrolase‐L1 (UCHL1) were measured in CSF and urine. Results 16/39 samples had OCBs unique to the CSF. CSF FLC levels (P < 0.0001) were higher in OCB‐positive subjects, with no difference in urinary FLC. CSF and urinary FLC did not correlate. There were a significant correlation between total CSF FLC and CSF neopterin in MS samples (correlation coefficient = 0.588, P = 0.016) and a strong correlation between CSF lambda FLC and CSF neopterin in MS samples (correlation coefficient = 0.875, P < 0.001). There was a strong correlation between urinary neopterin/creatinine levels and urinary total FLC/protein levels (correlation coefficient = 0.452, P = 0.004). Only three CSF samples (8%) had detectable levels of UCHL1. 18/38 (48%) (8/15 MS and 10/23 control) urine samples had detectable levels of UCLH1. Conclusions This study confirms the relationship between CSF OCBs and CSF FLCs, highlighting the importance of intrathecal B‐ and plasma‐cell activation in MS. There is a relationship between CSF FLC and CSF neopterin in MS, highlighting the multifaceted immune activation seen in MS. Correlations in the OCB‐positive group highlight the multifaceted immune activation seen in MS. Further studies are required to evaluate CSF and urinary biomarkers.Keywords
This publication has 33 references indexed in Scilit:
- Neurofilaments as biomarkers in multiple sclerosisMultiple Sclerosis Journal, 2012
- Biomarkers of disease activity in multiple sclerosisJournal of the Neurological Sciences, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Accuracy of diagnostic tests in multiple sclerosis - a systematic reviewActa Neurologica Scandinavica, 2010
- Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosisJournal of Neuroimmunology, 2010
- Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple SclerosisArchives of Neurology, 2005
- Development of biomarkers in multiple sclerosisBrain, 2004
- The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trialsMultiple Sclerosis Journal, 2002
- The role of nitric oxide in multiple sclerosisThe Lancet Neurology, 2002
- The psychometric properties of clinical rating scales used in multiple sclerosisBrain, 1999